<!doctype html><html><head><meta charset=utf-8><title>Late-stage MS associated with protein in spinal cord which blocks vitamin D</title>
<link rel=stylesheet href="/css/main.css?v=1751038173"><link rel=stylesheet href="/css/pagination.css?v=1751038173"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1751038173"></script><script src="/js/search.js?v=1751038173"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Late-stage MS associated with protein in spinal cord which blocks vitamin D</h1><time>January 29, 2013</time><div data-pagefind-body><h2 id=vitamin-d-binding-protein-in-cerebrospinal-fluid-is-associated-with-multiple-sclerosis-progression>Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.</h2><p>Mol Neurobiol. 2013 Jan 22.</p><p>Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, Liu S.</p><p>Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong, 250012, People&rsquo;s Republic of China.</p><p>Multiple sclerosis is a neurological disorder that presents with symptoms including inflammation, neurodegeneration, and demyelination of the central nervous system (CNS).</p><p><strong>Secondary progressive multiple sclerosis (SPMS)</strong> manifests with serious physical disability. To quantitatively analyze differential protein expression in patients with SPMS, we performed two-dimensional fluorescence difference in-gel electrophoresis, followed by mass spectrometry on the cerebrospinal fluid of these patients and patients with other neurological diseases.</p><p><strong>Vitamin D-binding protein</strong> (DBP), gelsolin, albumin, etc. showed more than a <strong>1.5-fold difference</strong> between the two groups. Based on these results, an experimental allergic encephalomyelitis (EAE) model of multiple sclerosis in Lewis rats was used to investigate DBP&rsquo;s role in the disease. Protein levels, mRNA transcripts, and ligands of DBP in different regions of the CNS were evaluated under various vitamin D intake levels.</p><p>Here, DBP levels increased in the experimental rat groups compared to the control groups regardless of vitamin D intake. Moreover, DBP mRNA levels varied in different parts of the CNS including spinal cords in the experimental groups. The observed differences between DBP protein and mRNA levels in the experimental groups&rsquo; spinal cords could be derived from the disruption of the blood-brain barrier. Furthermore, an interaction between DBP and actin was confirmed using coimmunoprecipitation and western blot. These results indicate a role for DBP in the actin scavenge system.</p><p>Moreover, in the experimental group that received oral vitamin D3 supplement, we observed both delayed onset and diminished severity of the disease.</p><p>When DBP was upregulated, however, the benefits from the vitamin D3 supplements were lost. Thus, <strong>we inferred that high levels of DBP were adverse to recovery</strong> .</p><p>In conclusion, here we observed upregulated DBP in the cerebrospinal fluid could serve as a specific diagnostic biomarker for the progression of multiple sclerosis. Next, we demonstrate the vital function of increased levels of free vitamin D metabolites for multiple sclerosis treatment. Finally, vitamin D supplements may be particularly beneficial for SPMS patients.</p><p>PMID: 23339019</p><p><strong><span style=color:#900>{PDF is behind a paywall, but here are the references}</span></strong></p><h2 id=references>References</h2><p>Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminate encephalomyelitis in monkeys. J Exp Med 58(1):39–53 CrossRef</p><p>Hafler DA (2004) Multiple sclerosis. J Clin Invest 113(6):788–794</p><p>Koch-Henriksen N, Sørensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9(5):520–532 CrossRef</p><p>Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 4(5):281–288 CrossRef</p><p>Ottervald J, Franzén B, Nilsson K, Andersson LI, Khademi M, Eriksson B et al (2010) Multiple sclerosis: identification and clinical evaluation of novel csf biomarkers. J Proteomics 73(6):1117–1132 CrossRef</p><p>Leary SM, Porter B, Thompson AJ (2005) Multiple sclerosis: diagnosis and the management of acute relapses. Postgrad Med J 81(955):302–308 CrossRef</p><p>Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343(20):1430–1438 CrossRef</p><p>Viswanathan S, Unlü M, Minden JS (2006) Two-dimensional difference gel electrophoresis. Nat Protoc 1(3):1351–1358 CrossRef</p><p>Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382(3):669–678 CrossRef</p><p>Disanto G, Ramagopalan SV, Para AE, Handunnetthi L (2011) The emerging role of vitamin d binding protein in multiple sclerosis. J Neurol 258(3):353–358 CrossRef</p><p>Schneider C, Schuetz G, Zollner TM (2009) Acute neuroinflammation in lewis rats—a model for acute multiple sclerosis relapses. J Neuroimmunol 213(1–2):84–90 CrossRef</p><p>Gomme PT, Bertolini J (2004) Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 22(7):340–345 CrossRef</p><p>White P, Cooke N (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11(8):320–327 CrossRef</p><p>Jirikowski GF, Kaunzner UW, Dief Ael E, Caldwell JD (2009) Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus. Histochem Cell Biol 131(3):365–370 CrossRef</p><p>Semra YK, Seidi OA, Sharief MK (2002) Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 122(1–2):132–139 CrossRef</p><p>Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62(1):60–65 CrossRef</p><p>Nordvik I, Myhr KM, Nyland H, Bjerve KS (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102(3):143–149 CrossRef</p><p>McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127 CrossRef</p><p>Liu S, Bai S, Qin Z, Yang Y, Cui Y, Qin Y (2009) Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. J Cell Mol Med 13(8A):1586–1603 CrossRef</p><p>Gressner OA, Lahme B, Gressner AM (2008) Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through ca(2+)-dependent interaction with the megalin/gp330 receptor. Clin Chim Acta 390(1–2):28–37 CrossRef</p><p>Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175(6):4119–4126</p><p>Li Y, Qin Z, Yang M, Qin Y, Lin C, Liu S (2011) Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients. J Cell Biochem 112(7):1930–1937 CrossRef</p><p>Karp NA, Lilley KS (2005) Maximising sensitivity for detecting changes in protein expression: experimental design using minimal cydyes. Proteomics 5(12):3105–3115 CrossRef</p><p>Tewari AK, Popova-Butler A, El-Mahdy MA, Zweier JL (2011) Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS. Proteomics 11(10):2051–2062 CrossRef</p><p>Dujmovic I (2011) Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. Mult Scler Int 2011:767083</p><p>Kułakowska A, Ciccarelli NJ, Wen Q, Mroczko B, Drozdowski W, Szmitkowski M et al (2010) Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol 10:107 CrossRef</p><p>Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30(6):445–456 CrossRef</p><p>McLeod JF, Cooke NE (1989) The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J Biol Chem 264(36):21760–21769</p><p>Paul C, Bolton C (1995) Inhibition of blood–brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int J Immunopharmacol 17(6):497–503 CrossRef</p><p>Bennett J, Basivireddy J, Kollar A, Biron KE, Reickmann P, Jefferies WA et al (2010) Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model eae. J Neuroimmunol 229(1–2):180–191 CrossRef</p><p>Haddad JG, Hu YZ, Kowalski MA, Laramore C, Ray K, Robzyk P et al (1992) Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (gc-globulin). Biochemistry 31(31):7174–7181 CrossRef</p><p>Lee WM, Galbraith RM (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326(20):1335–1341 CrossRef</p><p>Haddad JG, Harper KD, Guoth M, Pietra GG, Sanger JW (1990) Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci U S A 87(4):1381–1385 CrossRef</p><p>Piquette CA, Robinson-Hill R, Webster RO (1994) Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by gc-globulin. J Leukoc Biol 55(3):349–354</p><p>Kew RR, Webster RO (1988) Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of c5a and c5a des arg. J Clin Invest 82(1):364–369 CrossRef</p><p>Gressner O, Meier U, Hillebrandt S, Wasmuth HE, Köhl J, Sauerbruch T et al (2007) Gc-globulin concentrations and c5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor c5. Clin Biochem 40(11):771–775 CrossRef</p><p>Shah AB, DiMartino SJ, Trujillo G, Kew RR (2006) Selective inhibition of the c5a chemotactic cofactor function of the vitamin D binding protein by 1,25(oh)2 vitamin d3. Mol Immunol 43(8):1109–1115 CrossRef</p><p>Head JF, Swamy N, Ray R (2002) Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5 a resolution. Biochemistry 41(29):9015–9020 CrossRef</p><p>Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832–2838 CrossRef</p><p>Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9(6):599–612 CrossRef</p><p>Nashold FE, Miller DJ, Hayes CE (2000) 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 103(2):171–179 CrossRef</p><p>Nashold FE, Hoag KA, Goverman J, Hayes CE (2001) Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 119(1):16–29 CrossRef</p><p>Hayes CE, Nashold FE, Spach KM, Pedersen LB (2003) The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 49(2):277–300</p><p>Carpenter TO, Zhang JH, Parra E, Ellis BK, Simpson C, Lee WM et al (2012) Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. J Bone Miner Res 28(1):213–221 CrossRef</p><p>Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case–control study. Cancer Res 72(5):1190–1198 CrossRef</p></div><hr class=tag-separator><div class=tags><span>Tags: </span><span class=tag>autoimmune</span>
<span class=tag>brain</span>
<span class=tag>cancer</span>
<span class=tag>child</span>
<span class=tag>childhood cancer</span>
<span class=tag>cognitive</span>
<span class=tag>genetics</span>
<span class=tag>high dose</span>
<span class=tag>intervention</span>
<span class=tag>multiple sclerosis</span>
<span class=tag>Multiple Sclerosis</span>
<span class=tag>pancreatic cancer</span>
<span class=tag>pediatric autoimmune</span>
<span class=tag>therapeutic intervention</span>
<span class=tag>Vit D Binding Protein</span>
<span class=tag>vitamin d</span>
<span class=tag>vitamin d binding</span>
<span class=tag>vitamin d blood test</span></div><div data-pagefind-meta=tags hidden>autoimmune, brain, cancer, child, childhood cancer, cognitive, genetics, high dose, intervention, multiple sclerosis, Multiple Sclerosis, pancreatic cancer, pediatric autoimmune, therapeutic intervention, Vit D Binding Protein, vitamin d, vitamin d binding, vitamin d blood test</div></article></div></div><script src="/js/lightspa.js?v=1751038173"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1751038173",indexUrl:"/search/search_index.json.gz?v=1751038173"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1751038173"></script><script src="/js/tiki-redirects.js?v=1751038173"></script></body></html>